Developing a rural Veterans Affairs health care research program: Diligence and unique resolutions

Abstract: Development and growth of a rural Veterans Affairs Medical Center (VAMC) research program is one way to provide best care. This article reports the steps and barriers to building a rural research centre, using examples from western North Carolina. One goal driving the research centre’s creation was to increase under-served communities in the research workforce and among participants enrolled in Veterans Health Administration (VHA) research. The VHA reports health care differences for 4.7 million rural and highly rural Veterans, with rural Veterans using VHA services differently than urban and suburban Veterans. A total of 58% of rural Veterans enroll in the VHA, compared with 37% of urban and suburban Veterans. To achieve optimal Veteran health, all Veteran sub-groups must be adequately represented in clinical research trials, but rural Veterans are currently not equally represented. Research centre development steps included: 1) hiring a program specialist to focus on developmental needs, 2) finding a local program assistant to address the details required to develop a research centre, 3) obtaining a designated regulatory staff member, 4) negotiating staff, space, and focus needs, 5) hiring an experienced researcher to support initial research efforts, and 6) networking with other VAMCs, hospitals, agencies, and universities to create a best-care community. This article outlines the development and growth of a rural Veterans Affairs Medical Center (VAMC) research program in western North Carolina, United States, and highlights approaches to staffing, funding, and networking. Building a viable research program is one means to improve rural Veteran clinical trial inclusion rates, reduce trial participant disparity, and optimally inform best-practice clinical care guidelines. Defining and creating a small VAMC research program requires diligence and unique solutions, including overcoming hiring hurdles, building collaborations across Veterans Affairs facilities, industry, and community, and carefully crafting development phases via communication, networking, and education to ensure a good fit at each step to solidify continued growth.

Read the full article
Report a problem with this article

Related articles

  • More for Researchers

    Identifying opioid relapse during COVID-19 using natural language processing of nationwide Veterans Health Administration electronic medical record data

    Abstract: Novel and automated means of opioid use and relapse risk detection are needed. Unstructured electronic medical record data, including written progress notes, can be mined for clinically relevant information, including the presence of substance use and relapse-critical markers of risk and recovery from opioid use disorder (OUD). In this study, we used natural language processing (NLP) to automate the extraction of opioid relapses, and the timing of these occurrences, from veteran patients' electronic medical record. We then demonstrated the utility of our NLP tool via analysis of pre-/post-COVID-19 opioid relapse trends among veterans with OUD. For this demonstration, we analyzed data from 107,606 veterans OUD enrolled in Veterans Health Administration, comparing a pandemic-exposed cohort (n = 53,803; January 2019-March 2021) to a matched prepandemic cohort (n = 53,803; October 2017-December 2019). The recall of our NLP tool was 75% and our precision was 94%, demonstrating moderate sensitivity and excellent specificity. Using the NLP tool, we found that the odds of opioid relapse postpandemic onset were proportionally higher compared to prepandemic trends, despite patients having fewer mental health encounters from which to derive instances of relapse postpandemic onset. In this research application of the tool, and as hypothesized, we found that opioid relapse risk was elevated postpandemic. The application of NLP Methods: to identify and monitor relapse risk holds promise for future surveillance, risk prevention, and clinical outcome research.